In Sjögren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation

Autoimmunity Reviews

Volumn 11, Issue 4, 2012, Pages 252-258

  Varin, Marie Michèle ^a   Guerrier, Thomas ^a   Devauchelle Pensec, Valérie ^a   Jamin, Christophe ^a   Youinou, Pierre ^a   Pers, Jacques Olivier ^a  

^a UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

Author keywords

Apoptosis; B lymphocyte; Epithelial cells; Sj gren's syndrome

Indexed keywords

FAS LIGAND; HISTONE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN KINASE C DELTA; PROTEOME;

APOPTOSIS; B LYMPHOCYTE; CELL LINE; CELL NUCLEUS; COCULTURE; EPITHELIUM CELL; EXTRACTION; HUMAN; IMMUNOFLUORESCENCE; REVIEW; SALIVARY GLAND; SJOEGREN SYNDROME; STAINING; T LYMPHOCYTE; TISSUE INJURY; TONSIL;

ACTIVE TRANSPORT, CELL NUCLEUS; APOPTOSIS; B-LYMPHOCYTES; CELL LINE; CELL NUCLEUS; CHILD; COCULTURE TECHNIQUES; ENZYME ACTIVATION; EPITHELIAL CELLS; HISTONES; HUMANS; PHOSPHORYLATION; PROTEIN KINASE C-DELTA; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 84857060945     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.10.005     Document Type: Review

References (40)

1. Mavragani C.P., Moutsopoulos H.M. The geoepidemiology of Sjögren's syndrome. Autoimmun Rev 2010, 9:305-310.
2. Youinou P., Pers J.O. The international symposium on Sjögren's syndrome in Brest: the "top of the tops" at the "tip of the tips". Autoimmun Rev 2010, 9:589-590.
3. Moutsopoulos H.M. Sjögren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol Aug 1994, 72(2):162-165.
4. Christodoulou M.I., Kapsogeorgou E.K., Moutsopoulos H.M. Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome. J Autoimmun 2010, 34:400-407.
5. Talal N., Bunim J.J. The development of malignant lymphoma in the course of Sjögren's syndrome. Am J Med 1964, 36:529-540.
6. Russell J.H., Ley T.J. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002, 20:323-370.
7. Youinou P., Devauchelle-Pensec V., Pers J.O. Significance of B cells and B cell clonality in Sjögren's syndrome. Arthritis Rheum 2010, 62:2605-2610.
8. Manganelli P., Fietta P. Apoptosis and Sjögren syndrome. Semin Arthritis Rheum 2003, 33:49-65.
9. Matsumura R., Umemiya K., Goto T., et al. IFNγ and TNFα induce Fas expression and anti-Fas-mediated apoptosis in a salivary ductal cell line. Clin Exp Rheumatol 2000, 18:311-318.
10. Matassa A.A., Kalkofen R.L., Carpenter L., Biden T.J., Reyland M.E. Inhibition of PKC-alpha induces a PKC-delta-dependent apoptotic program in salivary epithelial cells. Cell Death Differ 2003, 10:269-277.
11. Blass M., Kronfeld I., Kazimirsky G., Blumberg P.M., Brodie C. Tyrosine phosphorylation of PKCδ is essential for its apoptotic effect in response to etoposide. Mol Cell Biol 2002, 22:182-195.
12. Yoshida K. PKCδ signaling: mechanisms of DNA damage response and apoptosis. Cell Signal 2007, 19:892-901.
13. Cross T., Griffiths G., Deacon E., et al. PKCδ is an apoptotic lamin kinase. Oncogene 2000, 4:2331-2337.
14. Hu Y., Liu Z., Yang S.J., Ye K. Acinus-provoked PKCδ isoform activation is essential for apoptotic chromatin condensation. Cell Death Differ 2007, 14:2035-2046.
15. Ajiro K. Histone H2B phosphorylation in mammalian apoptotic cells. An association with DNA fragmentation. J Biol Chem 2000, 275:439-443.
16. Vitali C., Bombardieri S., Jonsson R. European study group on classification criteria for Sjögren's syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
17. Daniels T.E. Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984, 27:147-156.
18. Datta R., Banach D., Kojima H., et al. Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents. Blood 1996, 88:1936-1943.
19. Fernandez-Capetillo O., Allis C.D., Nussenzweig A. Phosphorylation of histone H2B at DNA double-strand breaks. J Exp Med 2004, 199:1671-1677.
20. Darmon A.J., Ley T.J., Nicholson D.W., Bleackley R.C. Cleavage of CPP32 by granzyme B represents a critical role for granzyme B in the induction of target cell DNA fragmentation. J Biol Chem 1996, 271:21709-21712.
21. Atkinson E.A., Barry M., Darmon A.J., et al. Cytotoxic T lymphocyte-assisted suicide. Caspase 3 activation is primarily the result of the direct action of granzyme B. J Biol Chem 1998, 273:21261-21266.
22. Limesand K.H., Barzen K.A., Sanders L.A., et al. Characterization of rat parotid and submandibular acinar cell apoptosis in primary culture. In Vitro Cell Dev Biol Anim 2003, 39:170-177.
23. Waterman S.A., Gordon T.P., Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum 2000, 43:1647-1654.
24. Pérez P., Goicovich E., Alliende C., et al. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 2000, 43:2807-2817.
25. Pérez P., Kwon Y.J., Alliende C., et al. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios. Arthritis Rheum 2005, 52:2751-2760.
26. Jimenez F., Aiba-Masago S., Al Hashimi I., et al. Activated caspase 3 and cleaved PARP in salivary epithelium suggest a pathogenetic mechanism for Sjögren's syndrome. Rheumatology (Oxford) 2002, 41:338-342.
27. Youinou P., Taher T.E., Pers J.O., Mageed R.A., Renaudineau Y. B lymphocyte cytokines and rheumatic autoimmune disease. Arthritis Rheum 2009, 60:1873-1880.
28. Harvey B.P., Quan T.E., Rudenga B.J., Roman R.M., Craft J., Mamula M.J. Editing antigen presentation: antigen transfer between human B lymphocytes and macrophages mediated by class A scavenger receptors. J Immunol 2008, 181:4043-4051.
29. Iwasaki A., Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010, 327:291-295.
30. Vinuesa C.G., Cook M.C. The molecular basis of lymphoid architecture and B cell responses: implications for immunodeficiency and immunopathology. Curr Mol Med 2001, 1:689-725.
31. Le Pottier L., Devauchelle V., Fautrel A., et al. Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 2009, 182:3540-3547.
32. Saraux A. The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren's syndrome. Autoimmun Rev 2010 Jul, 9(9):609-614.
33. Tobón G.J., Saraux A., Pers J.O., Youinou P. Emerging biotherapies for Sjögren's syndrome. Expert Opin Emerg Drugs 2010, 15:269-282.
34. Pers J.O., Devauchelle V., Daridon C., et al. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome. Arthritis Rheum 2007, 56:1464-1477.
35. Silverman G.J., Weisman S. Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Arthritis Rheum 2003, 48:1484-1492.
36. Eisenberg R. Update on rituximab. Ann Rheum Dis 2005, 64:iv55-iv57.
37. Gürcan H.M., Keskin D.B., Stern J.N., Nitzberg M.A., Shekhani H., Ahmed A.R. A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol 2009, 9:10-25.
38. Mecklenbräuker I., Kalled S.L., Leitges M., Mackay F., Tarakhovsky A. Regulation of B-cell survival by BAFF-dependent PKCδ-mediated nuclear signalling. Nature 2004, 431:456-461.
39. Varin M.M., Le Pottier L., Youinou P., Saulep D., Mackay F., Pers J.O. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF. Autoimmun Rev 2010, 9:604-608.
40. Daridon C., Devauchelle V., Hutin P., et al. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2007, 56:1134-1144.